Up until now, NICE has recommended that those with a 10% or higher risk over ten years of a cardiovascular event should be offered a statin – guidance that remains unchanged.
Now, it is also recommending that statins can be considered as part of shared decision-making for those who have not had a cardiovascular disease (CVD) event with a ten-year CVD risk score of less than 10%.
The change comes after the independent committee updating the NICE guideline on CVD risk assessment and reduction considered new evidence on the side effects and safety of statins…
